$ZETA
Zeta Global Holdings Corp.

2024 Q3 Form 10-Q Financial Statement

#000095017024124619 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $268.3M
YoY Change 41.97%
Cost Of Revenue $105.7M
YoY Change 43.78%
Gross Profit $162.6M
YoY Change 40.81%
Gross Profit Margin 60.62%
Selling, General & Admin $135.0M
YoY Change 11.26%
% of Gross Profit 83.03%
Research & Development $22.81M
YoY Change 26.27%
% of Gross Profit 14.02%
Depreciation & Amortization $12.59M
YoY Change -4.84%
% of Gross Profit 7.74%
Operating Expenses $157.8M
YoY Change 13.2%
Operating Profit -$12.38M
YoY Change -66.69%
Interest Expense $1.945M
YoY Change -32.79%
% of Operating Profit
Other Income/Expense, Net -$4.796M
YoY Change -10.02%
Pretax Income -$17.18M
YoY Change -59.58%
Income Tax $200.0K
% Of Pretax Income
Net Earnings -$17.38M
YoY Change -59.67%
Net Earnings / Revenue -6.48%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.09
COMMON SHARES
Basic Shares Outstanding 187.9M
Diluted Shares Outstanding 187.9M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $418.5M
YoY Change 246.47%
Cash & Equivalents $418.5M
Short-Term Investments
Other Short-Term Assets $1.697M
YoY Change -7.52%
Inventory
Prepaid Expenses $9.699M
Receivables $203.7M
Other Receivables $0.00
Total Short-Term Assets $633.6M
YoY Change 135.09%
LONG-TERM ASSETS
Property, Plant & Equipment $7.383M
YoY Change -0.98%
Goodwill $140.9M
YoY Change 0.02%
Intangibles $43.03M
YoY Change -14.11%
Long-Term Investments
YoY Change
Other Assets $5.898M
YoY Change 73.32%
Total Long-Term Assets $235.4M
YoY Change -2.64%
TOTAL ASSETS
Total Short-Term Assets $633.6M
Total Long-Term Assets $235.4M
Total Assets $869.1M
YoY Change 69.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.49M
YoY Change -1.16%
Accrued Expenses $107.7M
YoY Change 47.2%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $190.9M
YoY Change 17.46%
LONG-TERM LIABILITIES
Long-Term Debt $196.1M
YoY Change 6.54%
Other Long-Term Liabilities $7.210M
YoY Change 10.85%
Total Long-Term Liabilities $203.3M
YoY Change 2.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $190.9M
Total Long-Term Liabilities $203.3M
Total Liabilities $394.2M
YoY Change 9.03%
SHAREHOLDERS EQUITY
Retained Earnings -$1.044B
YoY Change 13.03%
Common Stock $1.520B
YoY Change 41.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $474.9M
YoY Change
Total Liabilities & Shareholders Equity $869.1M
YoY Change 69.96%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$17.38M
YoY Change -59.67%
Depreciation, Depletion And Amortization $12.59M
YoY Change -4.84%
Cash From Operating Activities $34.40M
YoY Change 50.69%
INVESTING ACTIVITIES
Capital Expenditures $8.791M
YoY Change -6.28%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.791M
YoY Change -6.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 238.1M
YoY Change -2572.5%
NET CHANGE
Cash From Operating Activities 34.40M
Cash From Investing Activities -8.791M
Cash From Financing Activities 238.1M
Net Change In Cash 263.7M
YoY Change 6803.48%
FREE CASH FLOW
Cash From Operating Activities $34.40M
Capital Expenditures $8.791M
Free Cash Flow $25.61M
YoY Change 90.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001851003
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40464
dei Entity Registrant Name
EntityRegistrantName
ZETA GLOBAL HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0814458
dei Entity Address Address Line1
EntityAddressAddressLine1
3 Park Ave, 33rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
967-5055
dei Security12b Title
Security12bTitle
Class A common stock
dei Trading Symbol
TradingSymbol
ZETA
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
418538000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131732000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4593000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3564000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
203711000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170131000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9699000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6269000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1697000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1622000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
633645000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
309754000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7383000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7452000
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
29377000
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
32124000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7985000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6603000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43032000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
48781000
CY2024Q3 us-gaap Goodwill
Goodwill
140919000
CY2023Q4 us-gaap Goodwill
Goodwill
140905000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
842000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
728000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5898000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4367000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
235436000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
240960000
CY2024Q3 us-gaap Assets
Assets
869081000
CY2023Q4 us-gaap Assets
Assets
550714000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
58486000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63572000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107658000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
85455000
CY2024Q3 zeta Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
12983000
CY2023Q4 zeta Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
17234000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3586000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3301000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8202000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6823000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
190915000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
176385000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
196089000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
184147000
CY2023Q4 zeta Acquisition Related Liabilities Non Current
AcquisitionRelatedLiabilitiesNonCurrent
3060000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7210000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6602000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
203299000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
193809000
CY2024Q3 us-gaap Liabilities
Liabilities
394214000
CY2023Q4 us-gaap Liabilities
Liabilities
370194000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1520044000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1140849000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1043544000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-958537000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1863000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2010000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
474867000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
180520000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
869081000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
550714000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268295000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
188984000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
691081000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518403000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
105652000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
73480000
us-gaap Cost Of Revenue
CostOfRevenue
273607000
us-gaap Cost Of Revenue
CostOfRevenue
189867000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50494000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50706000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150459000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154022000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
84548000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70669000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
231567000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
215714000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22807000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18062000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
66407000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53924000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12590000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13233000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
39295000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37654000
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4583000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4583000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
203000
us-gaap Restructuring Charges
RestructuringCharges
2845000
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
280674000
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
226150000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
765918000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
654229000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12379000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-37166000
us-gaap Operating Income Loss
OperatingIncomeLoss
-74837000
us-gaap Operating Income Loss
OperatingIncomeLoss
-135826000
CY2024Q3 us-gaap Interest Expense
InterestExpense
1945000
CY2023Q3 us-gaap Interest Expense
InterestExpense
2894000
us-gaap Interest Expense
InterestExpense
7130000
us-gaap Interest Expense
InterestExpense
8139000
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2851000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2436000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1958000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7138000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4796000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5330000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9088000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15277000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17175000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42496000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83925000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151103000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
590000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1082000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1097000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-17375000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43086000
us-gaap Net Income Loss
NetIncomeLoss
-85007000
us-gaap Net Income Loss
NetIncomeLoss
-152200000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
146000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-283000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
147000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-78000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17229000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43369000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84860000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-152278000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17375000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43086000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-85007000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-152200000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187905129
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158055789
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179035728
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154262386
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187905129
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158055789
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179035728
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154262386
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47177000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57672000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
151974000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179746000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
180520000
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3466000
CY2024Q1 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
434000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53729000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-39566000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
191601000
CY2024Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
667000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1525000
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2919000
CY2024Q2 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
1407000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52780000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-28066000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
217046000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
228956000
CY2024Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1125000
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3889000
CY2024Q3 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
1143000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47715000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
146000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-17375000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
474867000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
128030000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6551000
CY2023Q1 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
41000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65214000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
147000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-56955000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
129926000
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
843000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1567000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1419000
CY2023Q2 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
41000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58491000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-52159000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
137348000
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
500000
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3517000
CY2023Q3 zeta Options Exercised During Period Value
OptionsExercisedDuringPeriodValue
141000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58675000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-283000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-43086000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
149778000
us-gaap Profit Loss
ProfitLoss
-85007000
us-gaap Profit Loss
ProfitLoss
-152200000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
39295000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37654000
us-gaap Share Based Compensation
ShareBasedCompensation
151974000
us-gaap Share Based Compensation
ShareBasedCompensation
179746000
zeta Provision For Deferred Income Taxes
ProvisionForDeferredIncomeTaxes
-113000
zeta Provision For Deferred Income Taxes
ProvisionForDeferredIncomeTaxes
-96000
zeta Change In The Fair Value Of Acquisition Related Liabilities
ChangeInTheFairValueOfAcquisitionRelatedLiabilities
1388000
zeta Change In The Fair Value Of Acquisition Related Liabilities
ChangeInTheFairValueOfAcquisitionRelatedLiabilities
6681000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-100000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1186000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34513000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33306000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3449000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-872000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
72000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-31000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1525000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
607000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
282000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-311000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3998000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22614000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
25208000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1225000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
608000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
72000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90178000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63561000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17458000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14886000
us-gaap Payments For Software
PaymentsForSoftware
12110000
us-gaap Payments For Software
PaymentsForSoftware
12344000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18246000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29568000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45476000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
7032000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
8710000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
207853000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
11250000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1525000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1567000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2982000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
224000
zeta Proceeds From Equity Capital Raise Net Of Issuance Cost
ProceedsFromEquityCapitalRaiseNetOfIssuanceCost
229327000
zeta Payments For Repurchase Of Shares
PaymentsForRepurchaseOfShares
12252000
zeta Payments For Repurchase Of Shares
PaymentsForRepurchaseOfShares
11487000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
196250000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
11250000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
226153000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18406000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
286806000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-314000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131732000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121110000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
418538000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120796000
us-gaap Interest Paid Net
InterestPaidNet
7492000
us-gaap Interest Paid Net
InterestPaidNet
7685000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1173000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1274000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1388000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
7670000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2250000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2634000
us-gaap Stock Issued1
StockIssued1
1792000
us-gaap Stock Issued1
StockIssued1
1343000
zeta Right To Use Asset Established
RightToUseAssetEstablished
2980000
zeta Operating Lease Liabilities Established
OperatingLeaseLiabilitiesEstablished
2980000
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
621000
us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
784000
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Organization and Background</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(a)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Nature of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Zeta Global Holdings Corp., a Delaware Corporation ("Zeta" or “Zeta Global Holdings”), and Zeta Global Corp., a Delaware Corporation and the operating company (“Zeta Global” individually, or collectively with Zeta Global Holdings Corp. and its consolidated entities, as context dictates, the “Company”), is a marketing technology company that uses proprietary data, artificial intelligence and software to create a technology platform that enables marketers to acquire, retain and grow customer relationships. The Company’s technology platform powers data-driven marketing programs for enterprises across a wide range of industries and utilizes all digital distribution channels including email, search, social, mobile, display and connected TV. Zeta Global was incorporated and began operations in October 2007.</span></p><p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(b)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Follow-on Offering</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 4, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley &amp; Co. LLC and Goldman Sachs &amp; Co. LLC, as representatives of the several underwriters named therein (collectively, the “underwriters”), and GPI Capital Gemini HoldCo LP (the “selling stockholder”) in connection with (i) the offering, issuance and sale by the Company of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10,304,716</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s Class A common stock, including </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,584,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, and (ii) the offering and sale by the selling stockholder of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,875,284</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s Class A Common Stock, including </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">396,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share, less underwriting discounts and commissions. The offering closed on September 6, 2024.</span></p><p style="text-indent:10.2%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The gross proceeds to the Company from the offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">242,161</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and net proceeds after underwriting discounts, commissions and offering expenses were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">228,946</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company did not receive any proceeds from the sale of its Class A common stock by the selling stockholder. The Company intends to use the net proceeds from the sale of shares for general corporate purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 zeta Gross Proceeds From Offering
GrossProceedsFromOffering
242161000
CY2024Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
228946000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11998000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5346000
CY2024Q3 zeta Contract With Customer Liability Amount Billed And Collected In Advance
ContractWithCustomerLiabilityAmountBilledAndCollectedInAdvance
19104000
CY2023Q3 zeta Contract With Customer Liability Amount Billed And Collected In Advance
ContractWithCustomerLiabilityAmountBilledAndCollectedInAdvance
4724000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18819000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4620000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3586000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3301000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
71600000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
102900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:1.133%;text-indent:-10.097%;padding-left:9.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(e)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:10.2%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer accounted for more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s total revenues during the nine months ended September 30, 2024 and 2023.</span></p><p style="text-indent:10.2%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration risk consist primarily of accounts receivable from customers. As of September 30, 2024 and December 31, 2023, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer, respectively, that represented more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the accounts receivables, net balance on the condensed unaudited consolidated balance sheets. The Company continuously monitors whether there is an expected credit loss arising from customers, and accordingly make provisions as warranted.</span></p>
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
168953000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
125921000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43032000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
155589000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
106808000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48781000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19113000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6243000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16692000
us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P2Y4M13D
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5962000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
20193000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11735000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3660000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1482000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43032000
CY2023Q4 us-gaap Goodwill
Goodwill
140905000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
14000
CY2024Q3 us-gaap Goodwill
Goodwill
140919000
CY2023Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
20294000
zeta Business Combination Payments To Acquire Businesses Gross
BusinessCombinationPaymentsToAcquireBusinessesGross
8699000
zeta Business Combination Change In Fair Value Ofearnout
BusinessCombinationChangeInFairValueOfearnout
1388000
CY2024Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
12983000
CY2024Q3 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
3911000
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
853000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
196089000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
184147000
CY2024Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3397000
CY2024Q3 zeta Deferred Financing Costs Remaining Existing Senior Secured Credit Facility
DeferredFinancingCostsRemainingExistingSeniorSecuredCreditFacility
580000
CY2024Q3 zeta Total Leverage Ratio
TotalLeverageRatio
3.25
CY2024Q3 zeta Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.25
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1250000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6250000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10000000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
12500000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20000000
CY2024Q3 zeta Long Term Debt Maturities Repayments Of Principal Year Five And Thereafter
LongTermDebtMaturitiesRepaymentsOfPrincipalYearFiveAndThereafter
150000000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
200000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000
CY2024Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
42477000
CY2024Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
57319000
CY2024Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
6012000
CY2024Q3 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
684000
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
106492000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47177000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57672000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
151974000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179746000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
49698329
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6671667
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
18680640
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
10.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
760161
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.72
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
36929195
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
10.92
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2619937
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.49
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y11M19D
CY2023Q4 zeta Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValuePerShare
0.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1832802
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
408205
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
136942
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.62
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3907592
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M29D
CY2024Q3 zeta Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValuePerShare
20.32
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
861116
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.61
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M15D
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7985000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6603000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2742000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1789000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7210000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6602000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
921000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3357000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2591000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2401000
CY2024Q3 zeta Lessee Operating Lease Liability Payments Due Year Four And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
2663000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11933000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1981000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9952000
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3889000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10274000
CY2023Q4 zeta Stock Repurchase Amount Unsettled
StockRepurchaseAmountUnsettled
1978000
CY2024Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
23.5
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1082000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17175000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83925000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
590000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1097000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.014
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42496000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151103000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-17375000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-43086000
us-gaap Profit Loss
ProfitLoss
-85007000
us-gaap Profit Loss
ProfitLoss
-152200000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187905129
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187905129
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158055789
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158055789
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179035728
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179035728
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154262386
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154262386
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-124619-index-headers.html Edgar Link pending
0000950170-24-124619-index.html Edgar Link pending
0000950170-24-124619.txt Edgar Link pending
0000950170-24-124619-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img141515387_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zeta-20240930.htm Edgar Link pending
zeta-20240930.xsd Edgar Link pending
zeta-ex31_1.htm Edgar Link pending
zeta-ex31_2.htm Edgar Link pending
zeta-ex32_1.htm Edgar Link pending
zeta-ex32_2.htm Edgar Link pending
zeta-20240930_htm.xml Edgar Link completed